Treating Presbyopia: New Options for an Old Problem

Pharmaceutical options for treatment of presbyopia will change the conversations between eye care providers and patients. These drugs will also act as a gateway for many more patients to visit optometrists and ophthalmologists—in particular presbyopic emmetropes. The current options simply do not completely satisfy all patients.

This webinar includes engaging discussions among the panel members related to underlying mechanisms of presbyopic changes; pharmacological properties of newly emerging presbyopia correcting drops and their mechanisms of action; and how presbyopia-correcting drops are likely to affect categories of patients based on individual characteristics.